CITY HILL ARTS TO PRODUCE INCREDIBLE MEDICAL THRILLER "CHASING MY CURE" BASED ON LIFE OF DR. DAVID FAJGENBAUM [Yahoo! Finance]
Halozyme Therapeutics, Inc. (HALO)
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
halozyme.com/investors/default.aspx
Company Research
Source: Yahoo! Finance
LOS ANGELES April 17, 2025 /PRNewswire/ -- City Hill Arts , the film and media production and financing company founded by biotech entrepreneur Jonathan E. Lim, M.D., has optioned and immediately put into development Chasing My Cure , a project based on the true story of David Fajgenbaum , a former star quarterback-turned-medical student who began a furious charge to save his own life when he was diagnosed with a rare and usually fatal illness. The story centers on Fajgenbaum, once a beast-like Georgetown quarterback and now a brilliant medical student, who is struck down with a fatal disease and given only six months to live. With no known cure, he gathers together an unconventional team to challenge every presumption of the medical establishment in a race to save his own life. Today, Dr. Fajgenbaum is a leader in the medical community. Dr. Fajgenbaum and his team at Every Cure and the University of Pennsylvania were recently chronicled in the New York Times for their work using
Show less
Read more
Impact Snapshot
Event Time:
HALO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HALO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HALO alerts
High impacting Halozyme Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
HALO
News
- Halozyme's Elektrofi Deal: Site-Of-Care Optionality (Rating Upgrade) [Seeking Alpha]Seeking Alpha
- Jim Lang Elected to Halozyme's Board of DirectorsPR Newswire
- Halozyme granted injunction in Germany barring Merck's subcutaneous Keytruda [Seeking Alpha]Seeking Alpha
- Halozyme Wins Preliminary Injunction Against Merck's Keytruda SC in Germany [Yahoo! Finance]Yahoo! Finance
- Halozyme Wins Preliminary Injunction Against Merck's Keytruda SC in GermanyPR Newswire
HALO
Earnings
- 11/3/25 - Beat
HALO
Sec Filings
- 12/11/25 - Form 4
- 12/9/25 - Form 8-K
- 12/8/25 - Form 8-K
- HALO's page on the SEC website